It is a relationship that we are proud of. At the core of the relationship is sharing knowledge to improve outcomes for patients. We want to ensure that patients and others have confidence that this relationship is open and transparent and this is why the pharmaceutical industry is taking the lead on disclosing details of payments and other benefits in kind made by industry to HCPs and HCOs.

This information will be published on the database - Disclosure​ UK. 

Disclosure UK is part of a Europe-wide initiative​ to increase transparency between pharmaceutical companies and the doctors, nurses, pharmacists and other health professionals and organisations it works with.

Click to search the database for 2015, 2016 and 2017 data.

Please note: the Disclosure UK database does not currently work in Edge. Please search using Chrome, Internet Explorer, Firefox or Safari.